CLSI I/LA30-P

Immunoassay Interference by Endogenous Antibodies; Proposed Guideline, ILA30PE

Clinical and Laboratory Standards Institute, 03/01/2007

Publisher: CLSI

File Format: PDF

$125.00$250.19

Description

Published:01/03/2007

Pages:40

Clinical and Laboratory Standards Institute document I/LA30-P - Immunoassay Interference by Endogenous Antibodies; Proposed Guideline presents information on the origin, nature, and prevalence of circulating endogenous antibodies, which cause interference with immunoassay results. The mechanisms of the interference along with some specific examples are included. To address the problem, recommendations for regulatory bodies, reagent manufacturers, and laboratorians are provided.

More CLSI standard pdf

CLSI NBS01-A6

Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard - Sixth Edition, NBS01A6E

$90.00 $180.00

CLSI NBS02-A2

Newborn Screening Follow-up; Approved Guideline - Second Edition, NSB02A2

$90.00 $180.00

CLSI MM14-A2 (R2018)

Design of Molecular Proficiency Testing/External Quality Assessment; Approved Guideline - Second Edition, MM14A2E

$90.00 $180.00

CLSI VET01-A4 and VET01-S2

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved Standard-Fourth Edition and Supplement, VET01A4E and VET01S2E

$144.00 $289.01